A review of pharmacotherapies for substance abuse

American Journal on Addictions

Volumn 5, Issue 4 SUPPL. 1, 1996, Pages

  Kosten, Thomas R ^a,b   McCance, Elinore ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ALPHACETYLMETHADOL; AMANTADINE; ATENOLOL; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BROMOCRIPTINE; BUPRENORPHINE; CARBAMAZEPINE; CITALOPRAM; CLONIDINE; DESIPRAMINE; DISULFIRAM; FLUOXETINE; LOFEXIDINE; MAZINDOL; METHADONE; NALOXONE; NALTREXONE; ONDANSETRON; OPIATE; PERGOLIDE; RITANSERIN; TRICYCLIC ANTIDEPRESSANT AGENT; VALPROIC ACID; VIQUALINE; ZIMELDINE;

DRUG DEPENDENCE; HUMAN; MAINTENANCE THERAPY; REVIEW; SUBSTANCE ABUSE;

EID: 0029826462     PISSN: 10550496     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1521-0391.1996.tb00479.x     Document Type: Review

References (70)

1. Sellers EM, Naranjo CA, Harrison M, et al: Diazepam loading: simplified treatment of alcohol withdrawal. Clin Pharmacol Ther 1983; 34:822-826
2. Gross GA: The use of propranolol as a method to manage acute alcohol detoxification. J Am Osteopath Assoc 1982; 82:206-207
3. Kraus ML, Gottlieb LD, Horwitz RL, et al: Randomized clinical trial of atenolol in patients with alcohol withdrawal. N Engl J Med 1985; 313:905-909
4. Baumgartner GR, Rowen RC: Clonidine vs. chlordiazepoxide in the management of acute alcohol withdrawal syndrome. Arch Intern Med 1987; 107:880-884
5. Brunning J, Mumford JP, Keaney FP: Lofexidine in alcohol withdrawal states. Alcohol 1986; 21:167
6. Banger M, Benkert O, Roschke J, et al: Nimodipine in acute alcohol withdrawal state. J Psychiatr Res 1992; 26:117-123
7. Gatti A, Munari L, Perretti A, et al: Sequential nimodipine-reduced glutathione treatment in alcoholic abstinence syndrome: preliminary experience. Minerva Med 1992; 83:277-281
8. Agricola R: Treatment of acute alcohol withdrawal syndrome with carbamazapine: a double-blind comparison with tiapride. J Int Med Res 1982; 10:160-165
9. Ballenger JC, Post RM: Mechanism of action of carbamazepine and anticonvulsants in affective illness, in Psychopharmacology: The Third Generation of Progress. Edited by Meltzer H, Bunney BSJr., New York, Raven, 1987, pp 567-576
10. Malcolm R, Ballenger JC, Sturgis ET, et al: Double-blind controlled trial comparing carbamazepine to oxazepam treatment of alcohol withdrawal. Am J Psychiatry 1989; 146:617-621
11. Ries RK, Roy-Byrne PP, Ward NG, et al: Carbamazepine treatment for benzodiazepine withdrawal. AmJ Psychiatry 1989; 146:536-537
12. Ritola E, Malinen L: A double-blind comparison of carbamazepine and clomethiazole in the treatment of alcohol withdrawal syndrome. Acta Psychiatr Scand 1981; 64:254-259
13. Shaw GK: Alcohol dependence and withdrawal. Br Med Bull 1982; 38:99-102
14. Gessner PK: Drug therapy of the alcohol withdrawal syndrome, in The Biochemistry and Pharmacology of Ethanol. Edited by Majchrowicz E, Noble E. New York, Plenum, 1979, pp 375-434
15. Wilbur R, Kulik FA: Anticonvulsant drugs in alcohol withdrawal: use of phenytoin, primidone, carbamazepine, valproic acid, and the sedative anticonvulsants. Am J Hosp Pharm 1981; 38:1138-1143
16. Lambie DG, Johnson RH, Vijayasenan ME, et al: Sodium valproate in the treatment of the alcohol withdrawal syndrome. Aust N Z J Psychiatry 1980; 14:213-215
17. Hillbom M, Tokola R, Kuusela V, et al: Prevention of alcohol withdrawal seizures with carbamazepine and valproic acid. Alcohol 1989; 6:223-226
18. Roy-Byrne PP, Ward NG, Donnelly PJ: Valproate in anxiety and withdrawal syndromes. J Clin Psychiatry 1989; 50:44-48
19. Volpicelli J, O'Brien C, Alterman A, et al: Naltrexone in the treatment of alcohol dependence. Arch Gen Psychiatry 1992; 49:867-880
20. O'Malley SS, Jaffe AJ, Chang G, et al: Naltrexone and coping skills therapy for alcohol dependence: a controlled study. Arch Gen Psychiatry 1992; 49:894-898
21. Sellers EM, Higgins GA, Sobell MB: 5-HT and alcohol abuse. Trends Pharmacol Sci 1992; 13:69-75
22. Bruno F, Casten G: Buspirone treatment of alcoholic patients. Data presented at the Hospital and Community Psychiatry Meeting, Boston, MA, 1987
23. Monti JM, Alterwain P: Ritanserin decreases alcohol intake in chronic alcoholics (letter). Lancet 1991; 337:60
24. Naranjo CA, Kadlec KE, Sanhueza P, et al: Fluoxetine differentially alters alcohol intake and other consummatory behaviors in problem drinkers. Clin Pharmacol Ther 1990; 47:490-498
25. Naranjo CA, Sullivan JT, Kadlec KE, et al: Differential effects of viqualine on alcohol intake and other consummatory behaviors. Clin Pharmacol Ther 1989; 46:301-309
26. Naranjo CA, Sellers EM, Sullivan JT, et al: The serotonin uptake inhibitor citalopram attenuates ethanol intake. Clin Pharmacol Ther 1987; 41:266-274
27. Charney DS, Riordan CE, Kleber HD, et al: Clonidine and naltrexone: a safe, effective and rapid treatment of abrupt withdrawal from methadone therapy. Arch Gen Psychiatry 1982; 39:1327-1332
28. Gold MS, Redmond DE, Kleber HD: Clonidine for opiate withdrawal. Lancet 1978; 1:929-930
29. Kleber HD, Topazian M, Gaspari J, et al: Clonidine and naltrexone in the outpatient treatment of heroin withdrawal. Am J Drug Alcohol Abuse 1987; 13:1-18
30. Vining E, Kosten TR, Kleber HD: Clinical utility of rapid clonidine-naltrexone detoxification for opioid abusers. Br J Addict 1988; 83:567-575
31. Kleber HD, Riordan CE, Rounsaville BJ, et al: Clonidine in outpatient detoxification from methadone maintenance. Arch Gen Psychiatry 1985; 42:391-398
32. Kosten TR, Kleber HD: Buprenorphine detoxification from opioid dependence: a pilot study. Life Sci 1988; 42:635-641
33. Lewis JW: Buprenorphine. Drug Alcohol Depend 1985; 14:363-372
34. Kosten TR, Krystal JH, Morgan CH, et al: Rapid detoxification using buprenorphine and naloxone (letter). Am J Psychiatry 1989b; 146:1349
35. Shi JM, O'Connor PG, Constantino JA, et al: Three methods of ambulatory opiate detoxification: preliminary results of a randomized clinical trial. NIDA Research Monograph #132 (NIH Publ No 93-3505). Washington, DC, U.S. Government Printing Office, 1993, p 309
36. Blaine JD, Thomas DB, Barnett G, et al: Levo-alpha-acetylmethadol (LAAM): clinical utility and pharmaceutical development, in Substance Abuse: Clinical Problems and Perspectives. Edited by Lowinson JH, Ruiz P. Baltimore, MD, Williams & Wilkins, 1981, pp 360-388
37. Ling W, Charuvastra VC, Kain SC, et al: Methadyl acetate and methadone as maintenance treatment for heroin addicts. Arch Gen Psychiatry 1976; 33:709-712
38. Jasinski DR, Pevnick JS, Griffith JD: Human pharmacology and abuse potential of the analgesic buprenorphine. Arch Gen Psychiatry 1978; 35:510-516
39. Johnson RE, Fudala PJ, Jaffe JH: A controlled trial of buprenorphine for opioid dependence. JAMA 1992; 267:2750-2755
40. Kosten TR, Schottenfeld RS, Ziedonis D, et al: Buprenorphine vs. methadone maintenance for opioid dependence. J Nerv Ment Dis 1993; 181:358-364
41. Bickel, WK, Stitzer ML, Bigelow GE, et al: Buprenorphine: dose-related blockade of opioid challenge effects in opioid-dependent humans. J Pharmacol Exp Ther 1989; 247:47-53
42. Schottenfeld RS, Pakes J, Ziedonis DM, et al: Buprenorphine: dose-related effects on cocaine and opiate use in cocaine-abusing, opioid-dependent humans. Biol Psychiatry 1993; 34:66-74
43. Quigley AJ, Bredemeyer DE, Seow SS: A case of buprenorphine abuse. Med J Aust 1984; 142:425-426
44. Tennant FS, Sagherian AA: Double-blind comparison of amantadine and bromocriptine for ambulatory withdrawal from cocaine dependence. Arch Intern Med 1987; 147:109-112
45. Morgan CH, Kosten TR, Gawin FH, et al: A pilot trial of amantadine for cocaine abuse. NIDA Res Monogr Ser 1988; 81:81-85
46. Weddington WW, Brown BS, Haertzen CA, et al: Comparison of amantadine and desipramine combined with psychotherapy for treatment of cocaine dependence. Am J Drug Alcohol Abuse 1991; 17:137-152
47. Dackis CA, Gold MS, Sweeney DR, et al: Single-dose bromocriptine reverses cocaine craving. Psychiatry Res 1987; 20:261-264
48. Giannini AJ, Baumgartel P: Bromocriptine in cocaine withdrawal. J Clin Pharmacol 1987; 27:267-270
49. Kosten TR, Morgan CM, Falcioni J, et al: Pharmacotherapy for cocaine-abusing, methadone-maintained patients using amantadine or desipramine. Arch Gen Psychiatry 1992a; 49:894-899
50. Khantzian EJ, Gawin F, Kleber HD, et al: Methylphenidate (Ritalin) treatment-of cocaine dependence: a preliminary report. J Subst Abuse Treat 1984; 1:107-112
51. Diakogiannis IA, Steinberg M, Kosten TR: Mazindol treatment of cocaine abuse: a double-blind investigation. NIDA Res Monogr Ser 1990; 105, p 514
52. Margolin A, Kosten T, Petrakis I, et al: Bupropion reduces cocaine abuse in methadone-maintained patients (letter). Arch Gen Psychiatry 1991; 48:87
53. Gawin FH, Allen D, Humblestone B: Outpatient treatment of "crack" cocaine smoking with flupenthixol decanoate. Arch Gen Psychiatry 1989a; 46:322-325
54. Gawin FH, Kleber HD, Byck R, et al: Desipramine facilitation of initial cocaine abstinence. Arch Gen Psychiatry 1989b; 46:117-121
55. Levin FR, Lehman AF: Meta-analysis of desipramine as an adjunct in the treatment of cocaine addiction. J Clin Psychopharmacol 1991; 11:374-378
56. Kosten TR, Silverman DG, Fleming J, et al: Intravenous cocaine challenges during naltrexone maintenance: a preliminary study. Biol Psychiatry 1992b; 32:543-548
57. Arndt IO, Dorozynsky L, Woody GE, et al: Desipramine treatment of cocaine dependence in methadone-maintained patients. Arch Gen Psychiatry 1992; 49:888-893
58. Weiss RD: Relapse to cocaine abuse after initiating desipramine treatment. JAMA 1988; 260: 2545-2546
59. Pollack MH, Rosenbaum JF: Fluoxetine treatment of cocaine abuse in heroin addicts. J Clin Psychiatry 1991; 52:31-33
60. Batki SL, Manfredi LB, Jacob P III, et al: Fluoxetine for cocaine dependence in methadone-mainte nance: quantitative plasma and urine cocaine, benzoylecognine concentration. J Clin Psychopharm 1993; 13:243-250
61. Kosten TA, Kosten TR, Gawin FH, et al: An open trial of sertraline for cocaine abuse. American Journal on Addictions, 1992; 1:349-353
62. Jenkins SW, Warfield NA, Blaine JD, et al: A pilotrial of gepirone vs. placebo in the treatment of cocaine dependency. Psychopharm Bull 1992; 28:21-26
63. Carroll K, Ziedonis D, O'Malley S, et al: Pharmacologic interventions for abusers of alcohol and cocaine: disulfiram vs. naltrexone. American Journal on Addictions 1993; 2:77-79
64. Halikas J, Kemp K, Kuhn K, et al: Carbamazepine for cocaine addiction? Lancet 1989; 1:623-624
65. Hatsukami D, Keenan R, Halikas J, et al: Effects of carbamazepine on acute responses to smoked cocaine-base in human cocaine users. Psychopharmacol 1991; 104:120-124
66. Gorelick DA, Weinhold LL, Henningfleld JE: Carbamazepine (CBZ) does not alter cocaine self-administration in human cocaine addicts (abstract). Committee on Problems of Drug Dependence Annual Scientific Meeting, 1993
67. Kosten TR, Kleber HD, Morgan CH: Treatment of cocaine abuse using buprenorphine. Biol Psychiatry 1989a; 26:637-639
68. Fudala PJ, Johnson RE, Jaffe JH: Outpatient comparison of buprenorphine and methadone maintenance, II: effects on cocaine usage, retention time in study, and missed clinic visits, in Committee on Problems of Drug Dependence, 1990. Edited by Harris LS. NIDA Research Monograph 105, DHHS Pub. No. (ADM)91-1753. Washington, DC, Supt. of Documents, U.S. Government Printing Office, 1991, pp 587-588
69. Oliveto AH, Kosten TR, Schottenfeld R, et al: A comparison of cocaine use in buprenorphine-and methadone-maintained cocaine users. American Journal on Addictions 1994; 3:43-48
70. Ziedonis DM, Kosten TR: Depression as a prognostic factor for pharmacological treatment of cocaine dependence. Psychopharmacol Bull 1991; 27:337-343